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Abstract
Surfactant protein D (SP-D), an innate immune molecule, has an indispensable role in host defense and regulation of
inflammation. Immune related functions regulated by SP-D include agglutination of pathogens, phagocytosis,
oxidative burst, antigen presentation, T lymphocyte proliferation, cytokine secretion, induction of apoptosis and
clearance of apoptotic cells. The present study unravels a novel ability of SP-D to reduce the viability of leukemic
cells (eosinophilic leukemic cell line, AML14.3D10; acute myeloid leukemia cell line, THP-1; acute lymphoid leukemia
cell lines, Jurkat, Raji; and human breast epithelial cell line, MCF-7), and explains the underlying mechanisms. SP-D
and a recombinant fragment of human SP-D (rhSP-D) induced G2/M phase cell cycle arrest, and dose and time-
dependent apoptosis in the AML14.3D10 eosinophilic leukemia cell line. Levels of various apoptotic markers viz.
activated p53, cleaved caspase-9 and PARP, along with G2/M checkpoints (p21 and Tyr15 phosphorylation of cdc2)
showed significant increase in these cells. We further attempted to elucidate the underlying mechanisms of rhSP-D
induced apoptosis using proteomic analysis. This approach identified large scale molecular changes initiated by SP-
D in a human cell for the first time. Among others, the proteomics analysis highlighted a decreased expression of
survival related proteins such as HMGA1, overexpression of proteins to protect the cells from oxidative burst, while a
drastic decrease in mitochondrial antioxidant defense system. rhSP-D mediated enhanced oxidative burst in
AML14.3D10 cells was confirmed, while antioxidant, N-acetyl-L-cysteine, abrogated the rhSP-D induced apoptosis.
The rhSP-D mediated reduced viability was specific to the cancer cell lines and viability of human PBMCs from
healthy controls was not affected. The study suggests involvement of SP-D in host’s immunosurveillance and
therapeutic potential of rhSP-D in the eosinophilic leukemia and cancers of other origins.
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Introduction
Recent studies show that particular immune cell types,
effector molecules, and pathways collectively form a functional
cancer immunosurveillance process that detects and eliminates
developing tumors [1]. The present study reports for the first
time, another secreted pattern recognition molecule of innate
immune system, Surfactant protein D (SP-D) that exerts
antileukemic properties. SP-D, a member of collectin family, is
composed of N-terminal collagen region and C-terminal C-type
lectin domain or carbohydrate recognition domain (CRD) region
[2]. It appears to perform a crucial role in linking innate and
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adaptive immunity [3]. Although initially discovered from the
lung where it is secreted by type II and Clara cells [4], extra-
pulmonary existence of SP-D has also been reported [5]. It also
has been proposed to be a useful biomarker in certain
carcinomas [6,7] and a range of lung-associated diseases [7,8].
Involvement of SP-D in immunosurveillance and
immunomodulation is well documented in pulmonary allergy
and asthma. Increasing the levels of SP-D in murine models of
allergy has been reported to regulate the immune cell
activation, pulmonary homeostasis and resistance to allergenic
challenge [5,9]. Exogenous administration of full-length SP-D
or rhSP-D has shown therapeutic effects in the hyper-
eosinophilic SP-D gene deficient mice [10]. Previously, we
reported that rhSP-D binds to human eosinophils and
selectively induces apoptosis, oxidative burst and CD69
expression in the sensitised eosinophils isolated from allergic
patients while eosinophils from healthy donors showed no
significant change [8]. Furthermore, eosinophils from healthy
donors, when primed with IL-5, exhibited an increase in
apoptosis following incubation with SP-D suggesting that the
healthy eosinophils in the absence of priming or activation do
not undergo SP-D induced apoptosis [8].
The AML14.3D10 cell line exhibits advanced eosinophilic
differentiation and is an outcome of autocrine activation of the
intracellular cytokine (IL-3/GM-CSF/IL-5) signaling pathways by
the endogenous GM-CSF production that also promote the cell
line proliferation [11,12]. In view of the immunomodulatory
properties of SP-D and its ability to selectively induce apoptosis
in the primed eosinophils, we investigated the interaction of
SP-D with the AML14.3D10 cell line.
Here, we report that the native and recombinant version of
full-length human SP-D, and rhSP-D (a recombinant
homotrimeric fragment of human SP-D) showed anti-leukemic
properties. There was a direct, dose, calcium and time
dependent interaction of rhSP-D with the AML14.3D10 cell line.
Treatment of the AML14.3D10 cells with rhSP-D resulted in
G2/M arrest that led to the induction of apoptosis. Proteomic
analysis revealed that rhSP-D treatment resulted in
differentially expressed proteins that belonged to the following
major functional categories: oxidoreductases and chaperones
(cell stress); inflammation and survival; ubiquitin proteasome
pathways; energy metabolism; transcription and translation;
RNA binding and metabolism; cytoskeleton; vesicle fusion;
synthesis and trafficking; metabolic enzymes and others. rhSP-
D resulted in enhanced oxidative burst and antioxidant N-
acetyl-L-cysteine (NAC) abrogated rhSP-D mediated apoptosis
in the cell line. The study showed a significant reduction in the
viability of acute myeloid leukemia cell lines (AML14.3D10 cell
and THP-1 cell line), acute lymphoid leukemia cell lines (Jurkat
and Raji) and human breast epithelial cell line (MCF-7), but
unaltered viability of human PBMCs from the healthy controls
in presence of rhSP-D. This suggests a possible role of SP-D
in the immune surveillance against the leukemic cells.
Materials and Methods
AML14.3D10 and other leukemia cell lines
The AML14.3D10 cell line was provided by Dr. Michael
Baumann and Dr. Cassandra Paul, Wright State University,
Dayton, Ohio [11,12]. The cell line exhibited advanced
eosinophilic differentiation and was grown in RPMI-1640
(Sigma) containing 10% fetal calf serum (FCS, Gibco BRL),
50μM 2-mercaptoethanol (Sigma), 1mM sodium pyruvate
(Sigma), and Gentamicin (50μg/ml) (Gibco BRL) [11,12].
The leukemia cells lines such as THP-1: acute monocytic
leukemia cell line, Jurkat: T lymphocyte acute cell leukemia cell
line, Raji: Burkitt’s B-cell lymphoma and a breast cancer cell
line of epithelial origin (MCF-7) were obtained from ATCC and
grown under standard culture conditions.
SP-D proteins
Native human SP-D was purified from the human amniotic
fluid, obtained from pregnant women at term undergoing
caesarean section at K E M Hospital and Seth G. S. Medical
College, Mumbai, who gave written informed consent (approval
from the ethics committees of NIRRH and K E M Hospital and
Seth G. S. Medical College), using procedures described
previously [13]. The protein preparation was found to be free
from IgG, IgM, and IgE contamination by ELISA using the anti-
human IgG, anti-human IgM, and anti-human IgE peroxidase
conjugates, respectively. The amount of endotoxin was found
to be 14pg/μg of SP-D. rhSP-D, composed of 8 gly-x-y repeats,
homotrimeric neck and CRD region, was expressed under the
bacteriophage T7 promoter in Escherichia coli as described
earlier [14]. Its identity was confirmed by N-terminal
sequencing, and was judged to be pure by SDS-PAGE and
immunoblotting. The amount of endotoxin present in the
preparations was estimated to be 4pg/μg of rhSP-D. A
recombinant full length SP-D was isolated as previously
described from supernatant of Chinese hamster ovary cells
stably transfected with a cDNA clone of full-length rat SP-D
[15]. Recombinant full length SP-D preparation contained
<0.25pg endotoxin/μg protein.
Viability of AML14.3D10 cells and cell-cycle analysis
To study rhSP-D induced apoptosis and cell death, following
assays were employed. Annexin V-FITC allowed the direct
evaluation of cells (Phosphatidylserine externalization) in the
very early stages in apoptosis before any nuclear changes
occurred; propidium iodide was added to distinguish membrane
permeabilized and late apoptotic cells [16], hypotonic
propidium iodide assay was used to study nuclear changes
(DNA fragmentation), where the appearance of sub-diploid
DNA peak is a specific marker of apoptosis [17]. Further, to
quantitate cell viability, MTT and trypan blue assays were
performed.
For the assays, 2 X 104 cells/100µl were plated in the 96-
well microtiter plates in the presence of rhSP-D (1, 2.5, 5, 10 or
20µg/ml) or recombinant full length SP-D (10µg/ml) or native
human SP-D (10µg/ml) or with the culture medium alone as
experimental control and incubated for different time intervals
(24, 48 and 72h). For MTT assay, 10µl MTT (5mg/ml stock)
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was added to each well and incubated for 4h. This was
followed by addition of 100µl of 0.04N HCl in isopropanol and
the absorbance was measured at 570nm [18]. In all cases,
rhSP-D or recombinant full length SP-D or native human SP-D,
was also added to wells containing medium alone to negate
any possible interference with the colorimetric MTT assay. For
studying the effect of rhSP-D mediated intracellular oxidative
burst on cell viability, the cells were incubated with NAC
(15mM) for 30 minutes followed by addition of rhSP-D
(10µg/ml) for 24h and 72h. For MTT assay in this case, the
cells were firstly rinsed with fresh media. The growth medium
was then replaced with media without NAC followed by
Modified MTT assay protocol as above.
The viability of AML14.3D10 cells was also determined by
trypan blue exclusion assay following 24, 48 and 72h of
incubation. The viable cell count was determined in five
different optical fields with at least 300 cells each.
For Annexin-V immunostaining assay, the protocol of
Annexin V-FITC apoptosis detection kit (Calbiochem) was
followed and the cells were immediately analyzed by flow
cytometry.
To analyze the cell cycle, and the proportion of apoptotic
cells displaying a hypo-diploid DNA peak to that of viable cells,
the method given Riccardi et al 2006 was followed [17]. For
this, the cells fixed with 70% ethanol were resuspended in 1X
PBS with 0.1% Triton X-100, 20µg/ml RNase and 70µg/ml
propidium iodide and analyzed by flow cytometry. To
demarcate the two populations of normal and apoptotic cells,
IL-5 incubated AML14.3D10 cells were included, as IL-5 is
known to maintain the viability of eosinophilic cells. The flow
cytometry data was acquired on at least 20,000 cells from each
sample on the Becton Dickinson FACS Calibur machine by the
Cell Quest Pro software. For the cell cycle analysis, the Dean/
Jett/Fox method of Flow Jo software was used.
To investigate whether an initial incubation with rhSP-D is
enough to achieve the induction of apoptosis, the effect of
removal of rhSP-D after an initial treatment was evaluated. For
this, the cells were incubated with rhSP-D (24h) and then
washed with media to remove rhSP-D, resuspended in the
media and further, incubated for 48h. The control cells were
given equivalent washing and incubation. Another set of
AML14.3D10 cells were treated with rhSP-D for 72h as a
positive control for this experiment.
The number of cells belonging to M region (apoptotic cells
displaying a hypo-diploid DNA peak) divided by the total cell
count was expressed as percentage cell apoptosis (% cell
apoptosis).
Proteomics of rhSP-D treated AML14.3D10 cells for
identification of differentially expressed proteins
To understand the molecular mechanisms involved in the
induction of rhSP-D mediated apoptosis, we carried out
proteomic analysis of AML14.3D10 cell line (3 × 105 cells/ml),
cultured in 10ml medium in 25cm2 tissue culture flasks, in the
presence and absence of rhSP-D (10µg/ml) (5% CO2, 37°C).
The cell line was treated with rhSP-D for 48h, a time period that
would sufficiently prime the cells for a distinct pathway, before
these cells extensively expressed proteins related to the
apoptotic pathways. After harvesting, the cells were washed
twice with cold salt free solution of Tris buffer sucrose (250mM
sucrose, 10mM Tris buffer, pH 7.2) at 4°C. Total cell protein
was extracted by sonication and interfering substances were
removed by TCA/acetone preparation. The lyophilized sample
was solubilized in the rehydration buffer (8M Urea, 2% CHAPS,
DTT) with the protease inhibitor cocktail (Roche) and PMSF
(Sigma) and estimated by the Bradford assay. Proteins (400µg)
untreated or rhSP-D treated cells were separated in first
dimension by the iso-electricfocusing on IPG strips, 17cm, pI
range 5-8 (Biorad) on Protean isoelectric focusing (IEF) cell
system (Biorad, Hercules, CA) and then in second dimension
by SDS-PAGE on 12% Laemmli gels, following the
manufacturers’ protocol. The gels were stained with reversible
silver stain or colloidal coomassie blue G250 [19]. 2-DE gel
images were acquired using Fluor-S MultiImager (Bio-Rad) and
image analysis was carried out using PDQuest Image Analysis
Software version 7.2 to identify protein spots showing
differential expression in the treated AML14.3D10 cells. The
images were taken under uniform settings for each experiment.
For this, 3-4 major spots in different areas of the gel were used
for fixing the coordinates. 2DE gels for rhSP-D treated and
untreated cells were normalized for small variations in staining
or protein loads using total optical density of the protein spots.
Only those spots with 3-fold or more changes in expression
intensity were selected for further MALDI-TOF-MS. The protein
spots were picked from colloidal coomassie blue protein gels
for the protein identifications by MALDI-TOF-MS. The colloidal
coomassie blue protein staining showed a similar protein profile
to that of silver stained gels and had sensitivity comparable to
silver staining.
These selected proteins spots were excised and subjected to
trypsin digestion. The tryptic digest was reconstituted in 0.6μl
buffer (50% ACN/ 0.1% TFA) and analyzed using 4800 MALDI-
TOF/TOF Proteomics Analyzer (Applied Biosystems) in
positive ion reflector mode. The instrument was calibrated to
<10ppm accuracy using calibration mixture of standard
peptides in the mass range 800-4000m/z. MS data of the
tryptic digests was acquired in an automatic mode. PMF
(peptide mass fingerprinting) data was interrogated for protein
identification with NCBI (National Center for Biotechnology
Information) database (Homo sapiens) using the Mascot
search program (Matrix Sciences). The analysis was done on
global proteomic solutions (GPS) software (Applied
Biosystems). The search parameters were partial methionine
oxidation, no fixed modification, one missed cleavage and a
mass tolerance of 100ppm, Mascot score ≥55, molecular mass
unrestricted; sequence coverage > 10%. The MALDI-TOF
analysis was repeated twice (from two gels) for all the samples
followed by the search.
For confirmation of protein identification by PMF, the
peptides were further subjected to fragmentation by tandem
MS (MS/MS). The MS/MS ion spectra of the peptides were
interrogated with NCBI database (Homo sapiens) for
confirmation of the protein IDs generated with PMF. A peptide
showing individual ion score of ≥30 was considered as
significant identification. The protein IDs that showed significant
score after MS and/or MS/MS analysis were considered. The
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functions and functional category of proteins were assigned
from the ExPASy database for biochemical pathways (http://
www.expasy.ch/tools/pathways/).
Detection of the expression levels of HMGA1 and
apoptosis-associated factors by western blot
The cells were treated with rhSP-D, the total cell extracts
were prepared in the ice-cold RIPA lysis buffer (Roche) and the
resulting supernatants were assayed for protein content (BCA,
Sigma). Equal amounts of the proteins (20-25μg) were
separated using 10-12% SDS-PAGE. The protein bands were
then transferred onto the nitrocellulose membranes and probed
with the appropriate primary antibodies [HMGA1 (Santa Cruz
Biotechnology Inc), phosphor p-53 (Santa Cruz Biotechnology
Inc.), p21 (Cell Signaling Technology) cleaved caspase 7 (Cell
Signaling Technology), caspase 9 (Cell Signaling Technology),
cyclin B1 (Santa Cruz Biotechnology Inc.), cyclin D (Cell
Signaling Technology), pcdc2 (Cell Signaling Technology) and
cleaved PARP (Cell Signaling Technology). ECL (Pierce)
detection system was used for immune detection. To show
equal protein loading in each lane, the immune blotting was
performed for β-actin (Abcam) or a non-specific protein band or
its ponceau stain was demonstrated. To compare and
quantitate the protein levels on blots, the ImageQuant TL
v2005 was used.
Intracellular oxidative burst and effect of NAC on rhSP-
D-mediated AML14.3D10 apoptosis
Intracellular oxidative burst of the cells was determined using
2’, 7’-dichlorofluorescein diacetate (DCFHDA) by flow
cytometry. For this, the treated cells were incubated with 5μM
DCFHDA in the culture medium for 15 minutes at 37°C. The
cells were thereafter washed twice with PBS, followed by
immediate scanning by flowcytometry and collection of FL1
data. NAC was used for studying the effect of rhSP-D mediated
intracellular oxidative burst on the apoptosis. For the assay, the
cells were incubated with NAC (15mM) (Sigma) for 30 minutes
followed by addition of rhSP-D (10µg/ml). The viability was
measured by MTT assay and trypan blue staining, at 24 and
72h as described above.
AML14.3D10 cell interaction with rhSP-D
To evaluate the involvement of CRD of SP-D in interaction
with AML14.3D10 cells, the effect of calcium on rhSP-D (1, 5
and 10µg/ml) binding with AML14.3D10 cells was analyzed in
presence of 2mM CaCl2 and/or 10mM EDTA using FITC
labeled rhSP-D, as described earlier [8]. Briefly, rhSP-D was
dialyzed extensively against FITC-labeling buffer (0.05M boric
acid and 0.2M sodium chloride, pH 9.2), followed by incubation
with FITC (20µl of 5mg/ml in dimethyl sulfoxide for each
milligram of protein) for 2h at room temperature. The labeled
proteins were dialyzed against buffer (0.1M Tris–HCl, pH 7.4,
0.1% w/v sodium azide and 0.2M NaCl) and stored at 4°C. The
flurochrome to protein ratio of 5–6:1 was considered optimum
for flow cytometric (FACS) studies. To evaluate any alterations
in functional activities of rhSP-D and SP-D induced by FITC
labeling, the unlabeled and FITC-labeled proteins were
compared for their binding to A. fumigatus conidia and for the
increase in fungicidal activity of neutrophils and alveolar
macrophages, as reported earlier [8]. No significant difference
was observed in the binding to conidia or fungicidal activity of
FITC-labeled and -unlabeled rhSP-D and SP-D.
For the binding, AML14.3D10 cells were incubated with
increasing concentrations of FITC-labeled rhSP-D for 45
minutes at 4°C in the staining buffer containing 2mM Ca2+ or
2mM Ca2+ and 10mM EDTA. The cells were washed and fixed
for analysis by FACS. The binding was also analyzed in the
presence or absence of maltose (100mM) using a polyclonal
antibody against human SP-D raised in rabbit (Millipore)
(1:100) followed by an anti-rabbit IgG-FITC (Invitrogen). FACS
analysis was performed on at least 5,000 cells using
FACScanTM (Becton Dickinson).
To validate the involvement of CRD in the interaction,
binding of rhSP-D (10µg/ml) to the AML14.3D10 cells was
analyzed in presence of monoclonal antibody against the CRD
of recombinant full length SP-D (Abcam) (recognizes CRD of
rhSP-D on western blot) or cellular debris. Both monoclonal
antibody and cellular debris [20] are known to bind the CRD of
SP-D and hence, are likely to inhibit the CRD mediated
interaction of SP-D with AML14.3D10 cells. The cellular debris
was prepared by repeated freezing thawing (5 times) of the
human PBMCs [20]. The set of antibodies used are as
mentioned above in the maltose inhibition assay. FACS
analysis was performed on at least 5,000 cells using
FACScanTM (Becton Dickinson).
rhSP-D treatment of human PBMCs and leukemia cell
lines of different origin
To characterize the anti-leukemic property of SP-D, various
leukemia cells lines such as THP-1, Jurkat, Raji and a breast
cancer cell line of epithelial origin (MCF-7) were used. For
human PBMCs, venous blood (5ml) was drawn from 5 healthy
adults (termed as healthy controls) (age 21–42 years, mean
30.2 years; two females) in heparinized tubes with written
consent for participation in the study. The study was approved
by the Institutional Human Ethical Committee, Institute of
Genomics and Integrative Biology (CSIR), and recommended
guidelines were followed during sample collection. Diluted
blood was subjected to Ficoll-density (HiMedia) centrifugation
and peripheral blood mononuclear cells (PBMCs) were isolated
from the buffy layer. Human PBMCs and the cell lines were
treated with or without rhSP-D (10 and 20µg/ml) for 48h. The
viability was then analyzed by MTT assay and Annexin V-
immunostaining as described above.
Statistical analysis
Statistics were calculated using GraphPad Prism™ (version
4.0 and 6.0 GraphPad Software). Data are expressed as Mean
± SE. Dose response relationships were evaluated using one-
way ANOVA or two-way ANOVA, and post hoc comparisons
between individual treatments were made using Tukey's test.
Instances involving two comparisons were evaluated by using
Student’s t-tests. A value of p<0.05 was considered statistically
significant.
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Results
SP-D decreased viability and induced apoptosis in
AML14.3D10 cells
rhSP-D significantly decreased the viability of AML14.3D10
cells in a dose and time dependent manner, with faster kinetics
at higher doses of rhSP-D (Figure 1A). Native SP-D and
recombinant full length SP-D (10µg/ml) also significantly
decreased the viability of the AML14.3D10 cells, as determined
by MTT and Trypan blue dye exclusion assays (Table 1).
A significant increase in the annexin-V positive cells was
observed on treatment of AML14.3D10 cells with rhSP-D (10
and 20µg/ml) (Figure 1B). The recombinant full length SP-D at
10 and 20µg/ml also showed a significant increase of
19.56±3.2% and 52.17±4% in the annexin-V positive cells
respectively at 48h. A significant increase (p<0.05) in the
apoptotic cell count showing hypodiploid PI stained DNA in
treatment with rhSP-D at 72h was observed (Figure 1C).
Therefore, at 72h, when MTT showed viability of 43±5.6%,
the cell membrane integrity was also lost to some extent and
trypan blue staining demonstrated 80% viable cells i.e. cells
with intact membrane integrity, while DNA fragmentation is
observed in 31.5±4% cells as observed by hypotonic PI assay.
The purified rhSP-D showed similar effect on the survival of
AML14.3D10 cells to that of native and recombinant full length
SP-D protein, the further studies were thus carried out using
rhSP-D.
rhSP-D resulted in accumulation of AML14.3D10 cells
in G2 phase
Treatment of AML14.3D10 cells with rhSP-D (10µg/ml) for
24h and 48h resulted in a significant accumulation of cells in
the G2 phase (Figure 2A). At 72h, rhSP-D resulted in a >20-
fold increase in the G2 population from 3.7% in control cells to
75.9% in rhSP-D treated cells (Figure 2B, top left and right
panel). There was also an increase in the sub G1 peak,
suggesting that the treated cells had now fragmented DNA, a
marker of cell apoptosis. Alternatively, the cells were incubated
with rhSP-D for the first 24h, and subsequently rhSP-D was
removed and cells maintained in the medium only for another
48h to complete an overall incubation of 72h (Figure 2B,
bottom right panel). These cells showed a cell cycle distribution
almost similar to the control untreated cells (Figure 2B, bottom
left and right panel). The experiment unequivocally established
that (a) rhSP-D induced a G2 block in AML14.3D10 cells, and
(b) continuous presence of rhSP-D was required for sustained
apoptosis, or removal of rhSP-D at 24h reversed the G2 block.
rhSP-D treated AML14.3D10 cells showed differential
expression of cell survival and redox-related proteins
Comparative analysis of silver stained 2DE-gels of rhSP-D
(10µg/ml) treated and untreated AML14.3D10 cells for 48h
showed a total of 134 proteins that exhibited a threefold- or
more change in the expression. PMF analysis after MALDI-
TOF MS and/or MALDI-TOF-TOF MS/MS analysis resulted in
the identification of 75 out of 134 proteins (Figure 3, Table S1).
These belonged to the following major functional categories:
oxidoreductases and chaperones (cell stress related
molecules); inflammation and survival; ubiquitin proteasome
pathways; energy metabolism; transcription and translation;
RNA binding and metabolism; cytoskeleton; vesicle fusion;
synthesis and trafficking; metabolic enzymes and others. The
differentially regulated proteins, their functional category, their
role in normal cells and their significance in rhSP-D mediated
apoptosis in eosinophilic cells are given in Table S2. The
proteomic profile of rhSP-D treated AML14.3D10 cells provided
us two important clues to rhSP-D mediated changes at the
molecular level. Firstly, the treated cells showed increased
expression of oxidoreductases and stress related molecules;
and secondly, survival related proteins such as high-mobility
group A1 (HMGA1) were found to be differentially expressed
(Table 2). While an increased expression of cell stress related
molecules was observed, the mitochondrial antioxidant defense
system related proteins showed a drastic decrease (Table 2).
We focused on validating the role of oxidative burst and
HMGA1 (one of the important survival related proteins) in
rhSP-D mediated reduced cell survival.
NAC inhibited the effect of rhSP-D on intracellular
oxidative burst and viability of AML14.3D10 cells
At 24h, rhSP-D (10µg/ml) [rhSP-D] showed a significant
increase in the oxidative burst (Figure 4C), however the cell
viability was not affected as observed by MTT and trypan blue
assay (Figure 4A and 4B). NAC decreased the oxidative burst
as well as the viability of the AML14.3D10 cells alone [NAC]
and of those treated with rhSP-D [NAC + rhSP-D] (Figure 4).
At 72h, rhSP-D [rhSP-D] treated cells showed a significant
increase in the oxidative burst and a decrease in the viability
(Figure 4). NAC treated cells [NAC] recovered from the
antioxidant stress and showed the viability similar to control
cells [Cells only]. Although NAC [NAC] had lost its effect on the
oxidative burst and viability at 72h, the cells pre-incubated with
NAC followed by rhSP-D treatment [NAC + rhSP-D] did not
show any significant change in oxidative burst and the viability
as compared to control cells [Cells only].
rhSP-D downregulated HMGA1 expression and induced
p53 dependent apoptosis
Downregulation of HMGA1 expression in the rhSP-D treated
cells, as evident in the proteomics profile, was confirmed by
western blot analysis. Expression of HMGA1 decreased in the
presence of rhSP-D (10µg/ml) at 48h and was not altered
significantly either at lower rhSP-D concentration (5µg/ml)
(Figure 5(i)) or at an early time point i.e. at 24h. The activated
p53 is a mediator of increased oxidative burst, G2/M phase
block, and apoptosis. Thus, we analyzed levels of activated
p53 in rhSP-D treated cells.
Treatment of AML14.3D10 cells with rhSP-D (10µg/ml) for
24h led to increased phosphorylation of p53 at the Serine 15
position (Figure 5(ii)). rhSP-D treatment caused cleavage of
caspase 9 (Figure 5(iii)) and PARP (Figure 5(iv)), the markers
of apoptosis. The caspase-7 was not cleaved (Figure 5(v)). In
addition, we found an increase in the expression of p21 levels
(Figure 5(vi)) and a significant increase in the phosphorylation
of cdc2 (Figure 5(viii)). Levels of cyclin B (Figure 5(vii)) were
unaltered after 24h treatment with rhSP-D.
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Figure 1.  rhSP-D decreases viability of AML14.3D10 cells in a dose and time dependent manner.  A. AML14.3D10 cells were
incubated with varying concentrations of rhSP-D (1, 5, 10 or 20µg/ml) for the indicated time intervals. The viability of AML14.3D10
cells was assessed using a modified MTT assay. Results expressed as % viability ± SEM of cells, from 5 independent experiments,
with 3 parallel samples in each experiment, in comparison to that of control (taken as 100%) at that time interval and compared by
one-way ANOVA and Tukey’s test, * p<0.05 versus control. B. The cells were treated with rhSP-D (10 or 20µg/ml) for 48h and the
apoptotic cells were detected by annexin-V-FITC/PI staining (i) Untreated, (ii) rhSP-D (10µg/ml), (iii) rhSP-D (20µg/ml), (iv) FSC and
SSC. The increase in PI positive cells in rhSP-D treated cells represents late apoptotic cells. The figure shows representative
scatter plots from one of the three independent experiments. C. Representative histograms for rhSP-D induced DNA fragmentation
in AML14.3D10 cells studied by hypotonic propidium iodide staining. AML14.3D10 cells were incubated with rhSP-D (10 and
20µg/ml) for 72h at 37°C. IL-5 (25ng/ml) incubated cells with intact DNA were used to define marker (M1). The marker (M1)
represents percentage apoptotic cells indicating the sub-diploid DNA. The figure shows representative histograms from one of the
three independent experiments.
doi: 10.1371/journal.pone.0085046.g001
SP-D Induces Apoptosis in Cancer Cell Lines
PLOS ONE | www.plosone.org 6 December 2013 | Volume 8 | Issue 12 | e85046
rhSP-D showed calcium dependent-binding via its
carbohydrate recognition domain
We have previously shown a direct interaction of rhSP-D with
sensitized eosinophils [8]. Thus, it was likely that the
modulation of cellular activities such as increase in oxidative
burst and apoptosis in AML cells were also mediated by a
direct interaction of rhSP-D with AML14.3D10 cells. FITC
labeled rhSP-D showed a dose and calcium dependent binding
to the AML14.3D10 cells (Figure 6A). Addition of EDTA
(10mM) reduced the rhSP-D binding to AML14.3D10 cells to
almost half at all rhSP-D concentration (Figure 6A). The
calcium dependence and EDTA inhibition of the rhSP-D
interaction with AML14.3D10 cells suggested the involvement
of CRD. The interaction was further validated for CRD
involvement by studying the binding of rhSP-D with
AML14.3D10 cells in the presence of maltose or monoclonal
antibody against the CRD or cellular debris.
The presence of maltose (100mM) (Figure 6B (iv)) however
did not significantly reduce binding of rhSP-D (10µg/ml) to
AML14.3D10 cells. The CRD recognizing MoAb did not bind to
AML14.3D10 bound rhSP-D suggesting that the CRD region of
rhSP-D was pre-occupied in binding to the cellular ligand (data
not shown). We hypothesized that the pre-incubation of this
MoAb with rhSP-D may competitively inhibit their interactions
with the AML14.3D10 cells. However, MoAb did not alter
interactions of rhSP-D (Figure 6B (ii)) with the AML14.3D10
cells. This suggested that affinity of the interaction of rhSP-D to
AML14.3D10 cells was probably strong enough to displace the
monoclonal antibody bound to rhSP-D. The cellular debris,
known to interact with CRD of SP-D, almost completely
inhibited the interaction of rhSP-D (10µg/ml) (Figure 6B (iii))
with the cells.
rhSP-D did not alter viability of healthy PBMCs but
reduced viability of various leukemia cell lines
We found that rhSP-D treatment did not significantly affect
the viability of PBMCs isolated from healthy donors at rhSP-D
concentrations 10 and 20µg/ml as checked by MTT assay
(Figure 7) and Annexin-V FITC staining (Figure S1). Further
the effect of rhSP-D on various leukemia cells lines belonging
to the category of acute myeloid leukemia (THP-1: acute
monocytic leukemia cell line), acute lymphoid leukemia (Jurkat:
T lymphocyte acute cell leukemia cell line, Raji: Burkitt’s B-cell
lymphoma) and a breast cancer cell line of epithelial origin
(MCF-7) were studied. rhSP-D (10µg/ml) resulted in a
significant decrease in the viability of Jurkat (60.2±3.9%), Raji
(42.0±1.1%) and MCF-7 cells (65.1±2%), while viability of
THP-1 was not significantly altered (Figure 7, n=3). Increasing
the concentration of rhSP-D to 20µg/ml further decreased the
viability of all the cell lines (including THP-1) by two-fold
suggesting a dose dependent effect (Figure 7). The study
indicated that rhSP-D specifically exerted its apoptotic effect on
the cancer cell lines.
Discussion
We report, for the first time, the ability of rhSP-D to
selectively reduce the survival of cancerous cells-AML14.3D10,
Jurkat, Raji, MCF-7 and THP-1, while survival of healthy
PBMCs was unaltered. In the presence of rhSP-D,
AML14.3D10 eosinophilic leukemia cells showed a significant
increase in the number of annexin-V positive cells, G2 phase
and DNA fragmentation suggesting induction of G2/M arrest
and apoptosis. Apoptosis is a sequential process of variable
duration, depending on inducer and cell type [21]. The
phosphatidylserine externalization (Annexin-V staining),
followed by mitochondrial dysfunction (MTT assay) and the
DNA fragmentation (hypotonic PI staining), followed by loss of
membrane integrity (trypan blue staining), were the events
observed during rhSP-D induced apoptosis in AML14.3D10 cell
line.
Proteomics profile showed differential expression of oxidative
burst related proteins, among others, in rhSP-D treated cells.
This suggested that probably, the localized production of ROS
induced by rhSP-D was compensated by the increased
expression of cellular reducing agents such as glutathione
synthetase and thioredoxins (Trx) and co-ordinated induction of
proteins with radical-scavenging properties and protective
activities as different electrophoretic forms of heat shock
protein 70 (HSP 70), chaperonins (mitochondrial chaperones),
calreticulin precursor variant, copper chaperone for superoxide
dismutase, etc [22,23]. We confirmed that rhSP-D significantly
up-regulated intracellular oxidative burst in AML cells, while
scavenging of ROS with NAC led to the inhibition of rhSP-D
induced apoptosis of AML cells. These results implied that the
increase in oxidative burst was likely to precede the induction
Table 1. Comparative effects of rhSP-D, recombinant full length SP-D and native human SP-D (10µg/ml) on the viability of
AML14.3D10 cells.
 Percent viable cells
Time Interval (h) rhSP-D Recombinant full   length SP-D Native human SP-D
24 89.3±3.2 91.5±2.1 90±2.6
48 63.9±4.3* 59±5.4* 75.4±3.6*
72 43±5.6* 50.2±4.8* 54.1±5.2*
Trypan blue dye exclusion assay (72h) 80±4.1* 79±2.6* -
Values expressed as % viability in the treated cells as compared to that of control cells at different time intervals. Data are Mean ± SE from 5 independent experiments, with
3 parallel samples in each experiment and evaluated by using Student’s t-tests, * p<0.05.
doi: 10.1371/journal.pone.0085046.t001
SP-D Induces Apoptosis in Cancer Cell Lines
PLOS ONE | www.plosone.org 7 December 2013 | Volume 8 | Issue 12 | e85046
Figure 2.  rhSP-D leads to G2/M phase arrest, while its removal post-24h reversed cell cycle arrest.  A. AML14.3D10 cells
were incubated in the presence of rhSP-D (10µg/ml) (Right panel) or in culture medium alone (control) (Left panel) for 24 or 48h,
Top and Bottom panel, respectively. B. AML14.3D10 cells were incubated continuously with or without rhSP-D (10µg/ml) for 72h
(rhSP-D-72h, Top right) and (Control-72h, Top left) respectively. Further, the cells were cultured in the presence of rhSP-D
(10µg/ml) for 24h initially, followed by washing and removal of rhSP-D. The cells were then cultured in culture media for another 48h
to complete an overall incubation of 72h (rhSP-D 24h-Release-72h, Bottom right); while the control cells were cultured without rhSP-
D for 24h and then given same treatment as test (Control 24h-Release-72h, Bottom left).The cell cycle distribution was determined
by flow cytometry of propidium iodide-stained DNA. The inset shows the percentage of total cells that are present in different
phases. The flow cytometry data was acquired on Becton Dickinson FACS Calibur machine using Cell Quest Pro software. The
figure shows representative histograms from one of the three independent experiments. The total population of cells has been
divided in the G1, S and G2 phases based on the Dean/Jett/Fox method of FlowJo software.
doi: 10.1371/journal.pone.0085046.g002
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of apoptosis in rhSP-D treated cells. Similar to rhSP-D, some of
the natural products with anti-leukemic effects have been
reported to enhance cytotoxicity by increasing the intracellular
oxidative burst [24]. In contrast to above, the mitochondrial
antioxidant defense system was compromised in rhSP-D
treated cells. There was a decreased expression of Ubiquinol-
cytochrome c reductase (complex III of the electron transport
chain), Peroxiredoxin 3 isoform b and Mitochondrial matrix
superoxide dismutase. Under such conditions with
mitochondrial antioxidant defense mechanisms compromised,
there is increased mitochondrial generation of reactive oxygen
species, irreversible damage of mitochondrial DNA, membrane
lipids and proteins, resulting in mitochondrial dysfunction. This
may trigger the intrinsic pathway of apoptosis and ultimately
cell death [25].
The proteomics approach identified large scale molecular
changes initiated by SP-D in a human cell for the first time.
Another important mechanism contributing to anti-leukemic
activity of rhSP-D was reduced expression of survival related
proteins such as HMGA1. HMGA1 is known to induce a
transformed phenotype in cultured, hematopoietic cells and
causes aggressive leukemia in transgenic mice
[26]. Conversely, inhibiting HMGA1 expression is found to
block phenotype transformation in a range of cancer cells [27]. 
HMGA1, an oncogenic transcription factor, is over-expressed in
various high-grade malignancies, including AML (acute myeloid
leukemia), ALL (acute lymphoid leukemia) and Burkitt’s
lymphoma [28]. In view of this, we also found that the cell lines
belonging to this category, AML (AML14.3D10 cell and THP-1
cell line), ALL (Jurkat and Raji) and human breast epithelial cell
line (MCF-7) showed decreased viability in presence of rhSP-
D.
Increased levels of p53 phosphorylated at Ser15 in rhSP-D
treated AML14.3D10 cells were plausibly mediated by oxidative
stress [29] and downregulated HMGA1. The proteomics data
also showed that on rhSP-D treatment heterogeneous nuclear
ribonucleoprotein K (hnRNP K) was upregulated that is known
to be induced by stress and is required for the induction of p53
target genes [30]. Increased levels of p21 were also observed
in rhSP-D treated AML14.3D10 cells. Activated p53 and
increased p21 expression cause the inactivation of cyclin B-
cdc2 complexes that are pivotal in regulating G2/M transition
and leads to either DNA repair or apoptosis [31,32]. The rhSP-
D treated cells also demonstrated an increased Tyr15
phosphorylation of cdc2, suggesting activation block on the
cdc2 [33]. Treatment of AML14.3D10 cells with rhSP-D
resulted in the activation of caspase-9, the intrinsic pathway of
apoptosis [34]. Once initiated, caspase-9 goes on to cleave
procaspase-3 or procaspase-7 that in turn cleaves several
cellular targets, including PARP, a well-known marker of
apoptosis [35]. Although, PARP was found to be cleaved in the
rhSP-D treated cells, cleavage of caspase-7 was not observed.
This indirectly suggests that an intermediate activation of
caspase-3 may be leading to the cleavage of PARP.
The proposed mechanism for the rhSP-D mediated
apoptosis in AML14.3D10 eosinophilic leukemic cells has been
Figure 3.  2-DE gel images of proteins extracted from AML14.3D10 cells.  Proteins were extracted from AML14.3D10 cells A.
untreated and B. treated with rhSP-D (10µg/ml) for 48h. Proteins (400µg) were separated by iso-electric focusing on IPG strips,
17cm, pI range 5-8 and SDS-PAGE on 12% Laemmli gels (n=3). Differentially expressed proteins (PDQuest Image Analysis
Software version 7.2) showing a change of ≥ 3 were identified by MALDI-TOF-MS and MALDI-TOF-MS-MS (75 proteins, marked
with arrows) (Table S1). The proteins marked in box are identified as HMGA1 proteins, which were downregulated on rhSP-D
treatment.
doi: 10.1371/journal.pone.0085046.g003
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depicted in Figure 8. At 24h, rhSP-D induced increased
oxidative stress, p53 Ser15 phosphorylation, elevated p21
expression and inhibitory Tyr15 phosphorylation of cdc2 that
would reduce the activity of Cdc2-cyclin B1 leading to G2/M
arrest [36]. rhSP-D mediated reduction in HMGA1 level was
observed at 48h which would further accumulate activated p53
and caspase 9 activation [37]. The removal of rhSP-D at 24h
reversed the G2/M cell cycle arrest in unsynchronus population
of AML14.3D10 cells suggesting that cells at a particular
growth phase were affected and it required continuous
presence of rhSP-D in the medium for the sustained induction
of apoptosis, or the downstream events that involve decrease
in HMGA1 levels might be required. The mechanism of rhSP-D
induced apoptosis in other leukemia cell lines, however needs
to be studied and confirmed.
rhSP-D primarily comprises of carbohydrate recognition
domain (CRD), ability of rhSP-D to reduce cell survival and
induce apoptosis similar to that of SP-D, suggested
involvement of CRD in these functions. We found that
interaction of SP-D with AML cells, as with a number of other
immune cells e.g. macrophages, dendritic cells and
neutrophils, could be through its CRD, and was enhanced in
the presence of calcium and inhibited by EDTA [38]. However,
maltose did not significantly affect rhSP-D binding to
AML14.3D10 cells. Similar to our results, maltose was not able
to inhibit the interaction of SP-D with T lymphocytes although
interacting through CRD [39]. The inhibition of the interaction of
Table 2. Differentially expressed proteins of AML14.3D10 in context to cell stress and cell survival, on rhSP-D treatment.
Locus tag/ Functional
category Spot No.   Protein description Biological Function
Increased/
Decreased
Cell Stress    
gi|4759212 8 Tubulin-specific chaperone a Tubulin complex assembly Decreased
gi|8922762 9 Membrane-type 1 matrix metalloproteinase cytoplasmictail binding protein-1
L-methionine salvage from methylthioadenosine
(Oxidoreductase) Decreased
gi|32483377 13 Peroxiredoxin 3 isoform b Mitochondrion-specific peroxidase Decreased
gi|7546411 14 Chain A, X-Ray Crystal Structure For Human ManganeseSuperoxide Dismutase, Q143a Mitochondrial matrix superoxide dismutase Decreased
gi|45768728 18 Ubiquinol-cytochrome c reductase, Rieske iron-sulfurpolypeptide 1 Mitochondrial respiratory chain complex III Decreased
gi|113422970 25 PREDICTED: similar to Copper chaperone for SOD Copper chaperone for superoxide dismutase(CCS) Increased
gi|62088106 32 Thioredoxin-like 1 Oxidoreductase Increased
gi|42794775 45 Thioredoxin domain containing 5 isoform 2 Thioredoxin domain containing protein Increased
gi|386758 47 GRP78 precursor Cytoprotective function; induced in Endoplasmicstress Increased
gi|6470150 48 GRP78 precursor Cytoprotective function; induced in Endoplasmicstress Increased
gi|6470150 49 GRP78 precursor Cytoprotective function; induced in Endoplasmicstress Increased
gi|3154294/7 52 Chaperonin Mitochondrial chaperone Increased
gi|24234688 54 Heat shock 70kDa protein 9B precursor Molecular Chaperone Increased
gi|21040386 55 HSPA9 protein Candidate tumor suppressor gene; control of cellproliferation; a chaperone Increased
gi|112491363 71 Chain A, Crystal Structure Of The Alpha Subunit OfHuman S- Adenosylmethionine Synthetase 2 Methionine Adenosyltransferase Activity Increased
gi|5174529 72 Methionine adenosyltransferase II, alpha Synthesis of S-adenosyl-methionine Increased
Survival and Inflammation related proteins   
gi|1633186 2 Chain A, Pkci-1-Apo+zinc Protein Kinase C Interacting (inhibitory) Decreased
gi|123377 20 High-mobility group I (HMGA1a) Cell survival protein, oncogenic phenotype Decreased
gi|62088704 56 Heterogeneous nuclear ribonucleoprotein K isoform avariant Cell cycle progression; induction of p53 genes Increased
gi|118084547 60 Aryl hydrocarbon receptor interacting protein Signal transducer activity Increased
gi|4505587 74 Platelet-activating factor acetylhydrolase, isoform Ib,gamma subunit 29kDa Lipid Metabolism Decreased
Proteins belonging to the categories (i) cell stress and (ii) inflammation and survival related proteins that showed altered expression (≥ 3-fold change) on treatment with
rhSP-D (10µg/ml) in AML14.3D10 cells ( n=3). Spot number relates to the protein spots marked on the 2-DE gel images of proteins extracted from rhSP-D treated and
untreated AML14.3D10 cells (Figure 3).
doi: 10.1371/journal.pone.0085046.t002
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Figure 4.  NAC decreases the effect of rhSP-D on viability and intracellular oxidative burst in AML14.3D10 cells.  The cells
were incubated with rhSP-D (10µg/ml) [rhSP-D], NAC (15 mM) [NAC] or pre-incubated with NAC for 30 minutes and then with rhSP-
D [NAC + rhSP-D] for 24 and 72h. [Cells only] are untreated cells in culture media. The viability of the cells was determined by A.
MTT assay and B. trypan blue exclusion assay. C. The intracellular release of H2O2 was determined by DCF by measuring FL1-H.
% Viable cells in MTT assay [Cells only] taken as 100% for determining viability in treated cells. The data is Mean ± SE of three
independent experiments and is compared by two-way ANOVA and Tukey’s multiple comparisons test* p<0.05 versus (Control)
(cells cultured in medium alone), $ p<0.05 versus (Cells + rhSP-D).
doi: 10.1371/journal.pone.0085046.g004
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SP-D with AML14.3D10 cells in presence of cell debris, further
suggested that the collagen domain is not involved in the
interaction and indirectly shows that the CRD may be involved
[20].
We report the ability of rhSP-D to selectively reduce the
survival of cancerous cells-AML14.3D10, Jurkat, Raji, MCF-7
and THP-1, while survival of healthy PBMCs was unaltered.
We could not find the exact reason for this differential behavior,
but such behavior of surfactant proteins is well documented.
Role of SP-D has been established to create homeostasis in
the allergy conditions [5,9,10]. We have also earlier found that
rhSP-D induced apoptosis in cells in activation phase as in
primed eosinophils while eosinophils from healthy individuals
did not show any change [8]. A similar response has been
reported earlier for another surfactant protein, SP-A, in
regulating chemotaxis of inflammatory BAL neutrophils while
peripheral neutrophils were unresponsive to SP-A towards
known chemoattractants, depending on the activation state of
the cells [40]. The leukemic cell lines are highly dividing and
some have increased levels of HMGA1, while PBMCs including
eosinophils, donot multiply and the HMGA1 protein levels are
hardly detectable in normal adult tissue [41] and thus these are
not dependent on the similar pathways for survival as leukemia
cell lines. Further whilst NAC, an antioxidant, is known to inhibit
spontaneous apoptosis in eosinophils [8]; it decreased the
viability of AML14.3D10 eosinophilic cell line (24 h). This can
be explained in view of earlier studies on tumor cells which
report that NADPH oxidase mediated generation of ROS is
required for survival of undifferentiated cells in human
promyelocytic leukemia cell line HL-60 [42]. The ROS
production has been observed in hematopoietic malignancies
as in acute myeloid leukemias (AML) [42] and required for cell
survival. rhSP-D resulted in an increase in oxidative burst in
both the cell types. But on one hand, in IL-5 primed
Figure 5.  rhSP-D treatment results in downregulation of HMGA1 levels and activates p53 and the apoptotic pathway.  (i)
AML14.3D10 cells treated with rhSP-D (5 and 10µg/ml) for 48h, were analyzed for HMGA1 expression by western blot. The cells
incubated with rhSP-D (10µg/ml) for 24h were also analyzed for the levels of (ii) phospho-p53 (Ser15), (iii) cleaved caspase 9, (iv)
cleaved PARP, (v) cleaved caspase 7, (vi) p21, (vii) cyclin B and (viii) phospho-cdc2 by immunoblotting. NS points to a non-specific
band that displays equal protein loading in different lanes. Cleavage of caspase 9 (iii) produces two bands of molecular mass 37
kDa (upper panel; black arrow) and 17 kDa (lower panel; black arrow). Hollow arrow points to a non-specific band that displays
equal protein loading. On the right is shown the quantification of the normalized values, *p<0.05, n=3 independent experiments.
doi: 10.1371/journal.pone.0085046.g005
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eosinophils, NAC could not affect rhSP-D mediated decrease
in cell viability; in eosinophilic cell line NAC inhibited rhSP-D
mediated apoptosis. In view of this, the anticancer agents have
been found to enhance cytotoxicity by increasing the NADPH
oxidase activity, similar to what we observed for SP-D [24].
In summary, SP-D acts as a potent inducer of apoptosis in
the eosinophilic and other cancer cells and enhances the
apoptotic cell uptake by macrophages [8]. This suggests that
SP-D may be an integral component of human innate immune
surveillance against cancer cells. The recombinant fragment of
human SP-D, rhSP-D, may be an interesting and novel
therapeutic strategy for such disorders.
Figure 6.  Involvement of CRD region of SP-D in its interaction with AML14.3D10 cells.  A. rhSP-D shows dose and calcium
dependent binding to AML14.3D10 cells. (i) AML14.3D10 cells were incubated with increasing concentrations of the FITC-
labeled rhSP-D in the presence of 2mM Ca2+ (Ca2+) or 2mM Ca2+ and 10mM EDTA (EDTA). Data are Mean ± SE of the mean
fluorescence of rhSP-D binding to the AML14.3D10 cells; n=3 independent experiments. Significant difference from Ca2+ alone: *
p<0.05 by Student’s t-test. (ii) A representative FACS histogram of AML14.3D10 cells with FITC-labeled rhSP-D (5µg/ml) showing
decreased binding in presence of EDTA. B. Engagement of CRD with cellular debris inhibits the interaction with AML14.3D10
cells. AML14.3D10 cells were incubated with rhSP-D (10µg/ml) (i) or rhSP-D (10µg/ml) pre-incubated with monoclonal antibody
against CRD domain of SP-D (ii) or rhSP-D (10µg/ml) in the presence of cellular debris (10 debris : 1 AML 14.3D10 cells) (iii) or
rhSP-D (10µg/ml) in the presence of 100 mM Maltose (iv). The cells were then washed and probed with anti-native human SP-D
raised in rabbit followed by incubation with anti-rabbit IgG-FITC. The cells were washed, and fixed and analyzed by FACS. %
indicates the percentage of fluorescent AML14.3D10 cells. The figure shows representative histograms from one of the three
independent experiments.
doi: 10.1371/journal.pone.0085046.g006
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Figure 7.  rhSP-D induces apoptosis in leukemia cell lines having different origins.   Human PBMCs, AML14.3D10, Jurkat,
Raji, THP-1 or MCF-7 cells were treated with rhSP-D (10 or 20µg/ml) for 48h. The viability of rhSP-D treated or untreated cells was
assessed by a modified MTT assay. Results are expressed as % viability ± SEM in comparison to control from 3 independent
experiments, and evaluated by Student’s t-tests, * p<0.05.
doi: 10.1371/journal.pone.0085046.g007
Figure 8.  Proposed mechanism for rhSP-D mediated apoptosis in AML14.3D10 eosinophilic leukemic cells.   rhSP-D leads
to oxidative stress and reduction in the levels of HMGA1. This possibly results in phosphorylation of p53 (Ser15) and Cdc2 (Tyr15).
p21 levels were also found to be upregulated. p21 elevation and Cdc2 phosphorylation contribute to Cdc2 inhibition leading to G2/M
arrest. Taken together, these overall changes lead to G2/M arrest followed by apoptosis. The superscripts (1-9) are the changes
observed during the study.
doi: 10.1371/journal.pone.0085046.g008
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